FAQ: Is There a Lawsuit Against Depo Provera?

How Can A Depo-provera Attorney from TruLaw Help You?

Our Depo-provera attorney at TruLaw is dedicated to supporting clients through the process of filing a Depo-provera lawsuit.

With extensive experience in handling pharmaceutical litigation, Jessica Paluch-Hoerman provides personalized support and advocacy to clients who have developed meningioma brain tumors after using Depo-provera.

We understand the challenges and emotional toll that a brain tumor diagnosis brings, and we’re committed to simplifying the legal process of seeking the compensation you deserve.

Meet the Lead Depo-provera Attorney at TruLaw

Meet our lead Depo-provera attorney:

• Jessica Paluch-Hoerman: With years of experience representing clients in pharmaceutical litigation cases, Jessica specializes in helping clients recover damages for medical expenses, pain and suffering, and various other forms of harm. Her dedication to holding negligent parties accountable for their actions has led to billions of dollars in compensation for her clients nationwide through verdicts and negotiated settlements.

How much does it cost to hire a Depo-provera lawyer from TruLaw?

At TruLaw, we believe financial concerns should never stand in the way of justice.

That’s why we operate on a contingency fee basis—with this approach, you won’t face any upfront costs for your legal representation.

Our fee is only collected if we are successful in securing compensation on your behalf.

This arrangement not only removes the financial risk of pursuing your case, it allows us to focus our resources on achieving a positive outcome in your case by:

• Court Filings and Legal Documentation: Handling all necessary paperwork, including filing fees and procedural documents, to ensure your case proceeds smoothly through the legal system.
• Research/Data Analysis: Dedicating resources to thoroughly investigate your case and gather the best possible evidence.
• Expert Testimony: Consulting with leading experts in the field to support your case and demonstrate the strength of your case to the court.
• Negotiations and Trial Preparation: Allocating resources to negotiate potential settlements and, if needed, preparing comprehensive trial strategies to present your case in court effectively.

Our investment in representing you demonstrates our unwavering commitment to seeking the compensation you deserve.

If you or a loved one developed a meningioma brain tumor after receiving Depo-provera injections, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a lawsuit against Depo-Provera today.

Legal Claims in Depo-Provera Lawsuits

Women filing Depo-Provera lawsuits base their cases on several legal theories, primarily focusing on product liability claims against Pfizer and its subsidiaries.

These lawsuits allege the pharmaceutical giant failed in its duty to protect consumers by withholding key safety information about brain tumor risks while continuing to market the injectable contraceptive as safe for long-term use.

Most cases involve plaintiffs who received multiple Depo-Provera injections over periods exceeding one year before developing meningiomas.

Their legal teams must establish a direct causal link between the medication and their brain tumors while demonstrating that Pfizer knew or should have known about these risks based on available scientific data and regulatory actions in other countries.

Failure to Warn Allegations

Lawsuits against Pfizer center on claims that the company knew about meningioma risks but failed to warn U.S. patients while providing clear warnings in other markets.

The Canadian Depo-Provera label has mentioned meningiomas as a potential “post-market adverse drug reaction” since approximately 2015, nearly a decade before similar warnings appeared on U.S. packaging.

European Union and United Kingdom labels explicitly list meningioma under “special warnings and precautions for use,” yet identical U.S. labels lacked these warnings despite containing the same medication formulation.

A study published in the British Medical Journal reports a 5.6-fold increased risk of meningiomas with prolonged use has become central to plaintiffs’ claims that Pfizer should have identified and disclosed these risks much earlier.

Manufacturing and Design Defect Claims

Beyond warning failures, lawsuits argue Pfizer had safer alternatives but chose not to promote them to protect market share for the original formulation.

Legal filings point to Depo-SubQ Provera 104, a subcutaneous version containing the same active ingredient but administered differently, as a potentially safer alternative that Pfizer “hardly markets in the US.”

The standard 150mg intramuscular injection delivers a substantially higher hormone load than many alternative contraceptive methods, which may directly contribute to the increased tumor risk.

Plaintiffs argue Pfizer should have either promoted the subcutaneous option or redesigned the original formula to mitigate risks while maintaining effectiveness as a contraceptive.

These design defect claims focus on whether Pfizer prioritized profits over user safety by continuing to market the higher-dose version without adequate warnings, even after developing alternative delivery methods.

Who Qualifies to File a Depo-Provera Lawsuit?

Thousands of women who received Depo-Provera injections may qualify for legal action if they later developed meningiomas.

As litigation expands, attorneys have established specific medical and legal criteria to determine eligibility for joining the MDL or filing individual claims against Pfizer.

Women considering legal action should consult with an attorney experienced in pharmaceutical litigation to evaluate their specific circumstances.

While each case is unique, clear patterns have emerged regarding who qualifies based on medical history, timing, and documentation requirements.

Medical Criteria for Lawsuit Eligibility

You may qualify to file a Depo-Provera lawsuit if doctors diagnosed you with a meningioma brain tumor after receiving at least two Depo-Provera injections.

Most law firms require documentation confirming you received multiple injections, as research shows the risk increases substantially after one year of use (typically equivalent to four quarterly injections).

The timeframe for Depo-Provera use must fall after 1992 when the FDA approved the drug for contraceptive purposes in the United States, though some firms accept cases with usage dating back to the 1960s when the medication was prescribed off-label.

Your meningioma diagnosis must be formally confirmed through medical imaging (MRI or CT scan) and potentially biopsy results or surgical records if the tumor was removed.

Attorneys typically prioritize cases involving tumors requiring surgical intervention, radiation treatment, or causing neurological symptoms, though all confirmed meningioma diagnoses may qualify.

Legal Eligibility Requirements

Each state enforces different statutes of limitations for product liability claims, typically ranging from 1-3 years from either your meningioma diagnosis or when you reasonably should have known about the connection to Depo-Provera.

Some states apply a “discovery rule” that extends the filing deadline if you couldn’t reasonably have known about the link between Depo-Provera and meningiomas until the recent publicity about this connection.

Your legal residency may impact where your case can be filed, though the MDL consolidation means federal cases will proceed through the Northern District of Florida regardless of where you live.

To prove your case, you’ll need comprehensive documentation including:

• Medical records confirming Depo-Provera prescriptions and injections
• Pharmacy records or insurance claims showing dates of administration
• Complete diagnostic records of your meningioma including imaging reports
• Surgical or treatment records related to your brain tumor
• Documentation of symptoms, disability, and impact on your quality of life

A qualified Depo-Provera attorney can help you obtain these records and determine if your case meets the established criteria for pursuing compensation through the current litigation.

The Legal Process for Depo-Provera Claims

Filing a claim related to Depo-Provera brain tumor injuries follows a structured legal pathway with multiple stages.

The process helps potential plaintiffs set realistic expectations about what lies ahead as they pursue compensation for their injuries.

The consolidation of cases into an MDL creates a more streamlined approach while still preserving the individual nature of each claim.

This balance allows for efficient handling of common issues while recognizing the unique aspects of each woman’s situation.

Steps in Filing a Depo-Provera Lawsuit

The process begins with a free initial consultation where attorneys evaluate your medical history, Depo-Provera usage, and meningioma diagnosis to determine if you have a viable claim against Pfizer.

After agreeing to representation, your legal team collects comprehensive medical documentation, including records from gynecologists who prescribed Depo-Provera, pharmacy records confirming injections, and all diagnostic and treatment records related to your meningioma.

Your attorney then prepares and files a complaint in either federal or state court, detailing how Depo-Provera caused your injuries and specifying the damages you’re seeking, including medical expenses, lost income, pain and suffering, and other losses.

Timeline for Depo-Provera Litigation

The appointment of Judge Rodgers, known for her efficient handling of mass tort cases, suggests this litigation may move faster than typical MDLs, which often take 3-5 years to resolve.

Her prompt selection of five pilot cases for early trials signals an accelerated timeline.

Several factors could influence how quickly cases proceed:

• The strength of scientific evidence linking Depo-Provera to meningiomas
• Pfizer’s litigation strategy and willingness to consider settlements
• Results of the initial bellwether trials
• The growing number of cases being filed nationwide
• Discovery of internal documents showing what Pfizer knew about risks and when

While no guarantees exist regarding timeframes, legal experts anticipate developments within 12-24 months, with possible settlement discussions beginning after the completion of the first bellwether trials, likely in late 2025 or early 2026.

Women considering filing should act promptly given statute of limitations concerns, as waiting too long could permanently bar their right to pursue compensation, regardless of the strength of their case.

TruLaw: Your Depo-Provera Law Firm

Depo-Provera lawsuits are being filed by individuals across the country who developed meningiomas after using the contraceptive injection.

TruLaw is currently accepting clients for the Depo-Provera litigation against Pfizer.

A few reasons to choose TruLaw for your Depo-Provera lawsuit include:

• If We Don’t Win, You Don’t Pay: The pharmaceutical liability lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
• Expertise: We have years of experience handling pharmaceutical cases similar to the Depo-Provera lawsuits, which helps us anticipate what we can expect to see in your case and the regulations we will be required to meet.
• Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.

If you or a loved one developed meningiomas after using Depo-Provera, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo-Provera litigation today.